HealthEquity, Inc. (NASDAQ:HQY) Given Average Recommendation of “Moderate Buy” by Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $112.92.

HQY has been the topic of several research analyst reports. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Raymond James upped their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. JMP Securities raised their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of HQY. Arcadia Investment Management Corp MI purchased a new position in HealthEquity in the fourth quarter worth $26,000. Transce3nd LLC purchased a new position in shares of HealthEquity in the 4th quarter worth about $29,000. Smartleaf Asset Management LLC grew its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in HealthEquity during the fourth quarter worth about $39,000. Finally, UMB Bank n.a. grew its position in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Price Performance

HealthEquity stock opened at $84.60 on Friday. The stock has a market capitalization of $7.33 billion, a price-to-earnings ratio of 77.61, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock’s 50 day moving average price is $105.20 and its two-hundred day moving average price is $95.51.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.